MoneyWorks4Me

Cadila Healthcare informs about press release

05 Feb 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated February 5, 2021 titled ‘Zydus completes large scale enrolment for two Phase III trials of Desidustat’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors at large.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..